Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niall M B Martin

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
FEBS Letters|January 27, 2009
Regulation of the activity and expression of ERK8 by DNA damageIva V Klevernic, Niall M B Martin, Philip Cohen
Journal of Biomolecular Screening|July 15, 2003
A FlashPlate assay for the identification of PARP-1 inhibitorsKrystyna J Dillon, Graeme C M Smith, Niall M B Martin
Cell Biochemistry and Biophysics|May 29, 2013
Deubiquitylating enzymes and DNA damage response pathwaysXavier Jacq, Mark Kemp, Niall M B Martin, et al.
Cancer Research|November 17, 2005
Efficient deletion of normal Brca2-deficient intestinal epithelium by poly(ADP-ribose) polymerase inhibition models potential prophylactic therapyTrevor Hay, Helen Jenkins, Owen J Sansom, et al.
Cancer Biology & Therapy|October 28, 2005
BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potencyNuala McCabe, Christopher J Lord, Andrew N J Tutt, et al.
Science Signaling|May 26, 2011
Progress in the function and regulation of ADP-RibosylationMichael O Hottiger, Mark Boothby, Friedrich Koch-Nolte, et al.
Molecular Cancer Therapeutics|March 21, 2013
Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancerMichael A Batey, Yan Zhao, Suzanne Kyle, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Phthalazinones 2: Optimisation and synthesis of novel potent inhibitors of poly(ADP-ribose)polymeraseXiao-Ling Cockcroft, Krystyna J Dillon, Lesley Dixon, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014Kurt G Pike, Karine Malagu, Marc G Hummersone, et al.
Organic & Biomolecular Chemistry|December 4, 2010
Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitorPeter T Sunderland, Archana Dhami, Mary F Mahon, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
FEBS Letters|January 27, 2009
Regulation of the activity and expression of ERK8 by DNA damageIva V Klevernic, Niall M B Martin, Philip Cohen
Journal of Biomolecular Screening|July 15, 2003
A FlashPlate assay for the identification of PARP-1 inhibitorsKrystyna J Dillon, Graeme C M Smith, Niall M B Martin
Cell Biochemistry and Biophysics|May 29, 2013
Deubiquitylating enzymes and DNA damage response pathwaysXavier Jacq, Mark Kemp, Niall M B Martin, et al.
Cancer Research|November 17, 2005
Efficient deletion of normal Brca2-deficient intestinal epithelium by poly(ADP-ribose) polymerase inhibition models potential prophylactic therapyTrevor Hay, Helen Jenkins, Owen J Sansom, et al.
Cancer Biology & Therapy|October 28, 2005
BRCA2-deficient CAPAN-1 cells are extremely sensitive to the inhibition of Poly (ADP-Ribose) polymerase: an issue of potencyNuala McCabe, Christopher J Lord, Andrew N J Tutt, et al.
Science Signaling|May 26, 2011
Progress in the function and regulation of ADP-RibosylationMichael O Hottiger, Mark Boothby, Friedrich Koch-Nolte, et al.
Molecular Cancer Therapeutics|March 21, 2013
Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancerMichael A Batey, Yan Zhao, Suzanne Kyle, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Phthalazinones 2: Optimisation and synthesis of novel potent inhibitors of poly(ADP-ribose)polymeraseXiao-Ling Cockcroft, Krystyna J Dillon, Lesley Dixon, et al.
Bioorganic & Medicinal Chemistry Letters|February 5, 2013
Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: the discovery of AZD8055 and AZD2014Kurt G Pike, Karine Malagu, Marc G Hummersone, et al.
Organic & Biomolecular Chemistry|December 4, 2010
Synthesis of 4-alkyl-, 4-aryl- and 4-arylamino-5-aminoisoquinolin-1-ones and identification of a new PARP-2 selective inhibitorPeter T Sunderland, Archana Dhami, Mary F Mahon, et al.
Pageof 3